GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract W81XWH20C0137SCANDINAVIAN BIOPHARMA HOLDING AB

Overview

Award facts

Period of performance
Sep 25, 2020 to Sep 30, 2028
Ends in 22 months
Modifications
12
Latest action Jun 5, 2026
Contract type
Definitive contract
PIID W81XWH20C0137

Description of requirement

THIS AWARD IS FOR THE DELIVERY OF A CGMP MANUFACTURED PRODUCT OF QUANTITY AND QUALITY THAT IT IS SUITABLE AND APPROPRIATE FOR USE IN PIVOTAL CLINICAL STUDIES TO DEMONSTRATE EFFICACY AGAINST ETEC IN ADULTS WITH THE GOAL OF FDA LICENSURE.

Dates and value

Award date
Signed on Sep 25, 2020
Current value
$51,663,682Base and exercised options
Potential value (if all options are exercised)
$51,663,682

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 15, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 5, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationSOLNA, STOCKHOLM, SWE
UEIZKASUJ7ZZC98
CAGE codeAYBAN
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org

Business types and certifications

For-profit organizationInternational organization

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Defense
  2. Defense Health Agency
  3. ARMY MED RES ACQ ACTIVITY
Funded by
  1. Department of Defense
  2. Defense Health Agency
  3. ARMY MMDA - MM
Funded from
Rdt&eProgram activities097-0130Federal accounts (agency financial reports)

Place of performance

Place of performance
21702-5012 Sweden

Classification and competition

Classification

Product or service (PSC)
Q517PHARMACY SERVICES (service)

Competition

Extent competed
Not competedC
Reason not competed
Only one source-other (FAR 6.302-1 other)ONE
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Fixed price level of effortB
Offers received
1

Solicitation and notices

Solicitation ID
W81XWH20R0005(as reported)
Solicitation date
Jul 27, 2020

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 25, 2020Base obligation at award: $8,119,774
Latest action
Jun 5, 2026 — Supplemental agreement (within scope)Modification P00012
Latest substantive action
Jun 5, 2026 — Supplemental agreement (within scope)Modification P00012
Latest funding action
May 4, 2026 — Funding onlyModification P00011; obligation change +$1,182,300; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)8
  • Funding only2
  • Other administrative action2
13 actions recorded, Sep 25, 2020 to Jun 5, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
SwedenSWE
Place of manufacture
Not a manufactured end productC
Sea transportation
UnknownU

Structure

Award or IDV
Award
Award type
Definitive contractD
IT commercial item category
Not IT products or servicesZ
DoD claimant program
ServicesS1
Awarding agency code
9700
Awarding sub-tier code
97DH
Contracting office code
HT9425
Transactions recorded under this award key
9

Funding

Funding agency code
9700
Funding sub-tier code
97DH
Funding office code
HT0986
Treasury accounts
  • 097-2022/2023-0130-000
  • 097-2023/2024-0130-000
  • 097-2024/2025-0130-000
  • 097-2025/2026-0130-000
  • 097-2026/2027-0130-000
Object classes
  • 25.5: Research and development contracts
  • 25.6: Medical care
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression